Wolf Haldenstein Investigating Semitool, Inc. Proposed Acquisition

Attorney Advertising. The law firm of Wolf Haldenstein Adler Freeman & Herz LLP is investigating possible breaches of fiduciary duty by the Board of Directors of Semitool, Inc. (“Semitool” or the “Company”) [NASDAQ:SMTL] arising out of the proposed acquisition of Semitool by Applied Materials, Inc. (“Applied Materials”).

On Tuesday, November 17, 2009, Semitool announced that Applied Materials will acquire Semitool in an all cash offer. Under the terms of the agreement, Semitool stockholders will receive cash of $11 in exchange for each share of Semitool common stock. However, the Company may not have adequately shopped itself around before entering into this transaction and, pursuant to this proposed transaction, Applied Materials may be underpaying for Semitool, thus unlawfully harming Semitool shareholders.

Wolf Haldenstein has been representing individual and institutional investors for many years, serving as lead counsel in numerous cases in U.S. federal and state courts. Please visit the Wolf Haldenstein website (http://www.whafh.com) for more information about the firm.

If you own Semitool common stock and you wish to discuss this matter with us, or have any questions concerning your rights and interests with regard to this matter, please contact:

    
      
        
          Gustavo Bruckner or Derek Behnke
        
      
      
        
          Wolf Haldenstein Adler Freeman
        
      
      
        
          & Herz LLP
        
      
      
        
          270 Madison Avenue
        
      
      
        
          

New York, New York 10016

        
      
      
        
          Phone Numbers:
        
        
          [phone]
        
      
      
        
        
        
        
        
          [phone]
        
      
      
        
        
        
        
        
           
        
      
      
        
          

Email:

[e-mail]

 

[e-mail]

Website:

http://www.whafh.com

Attorney Advertising. Prior Results Do Not Guarantee A Similar Outcome.